Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varicella Vaccine Booster Intervals in Children
NCT06994052Phase 4Completed
- Sponsor
- Sinovac Biotech Ltd.
- Start
- Sep 2024
- Primary completion
- Nov 2024
- Modality
- Prophylactic Vaccines, DNA Vaccines, Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 4 trial of varicella vaccine live in varicella (VZV), sponsored by Sinovac Biotech Ltd.. Started Sep 2024; status: completed.
02
Drugs
varicella vaccine live
03
Conditions
varicella (VZV)
Beyond the preview
Go deeper on NCT06994052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06994052.